Tuesday July 25th 2017

The two faces of neuromyelitis optica

Over the past 15 years, it had seemed as if neuromyelitis optica (NMO) might be a distinct and homogeneous subtype of CNS demyelinating disease distinguishable from the heterogeneous assortment of patients captured by the umbrella diagnosis of “multiple sclerosis (MS).” NMO had distinctive clinical, radiologic, and pathologic characteristics and, in most cases, a highly specific biomarker, aquaporin-4 (AQP4) autoantibodies, was detectable.1 However, recent observations might be interpreted as dashing hopes of NMO being a single disorder with uniform pathogenesis. The clinical presentation of NMO is increasingly recognized as heterogeneous. A variety of cerebral, diencephalic, and brainstem presentations1,2 may occur as presenting features or over the course of the disease, which may have b…

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

From:  

The two faces of neuromyelitis optica

Leave a Comment

More from category

12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging
12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging

/About-the-Society/News/12-National-Patient-Advocacy-Organizations-Urge-Se [Read More]

Low vitamin D may affect recovery of injured corneas
Low vitamin D may affect recovery of injured corneas

Injury or disease in combination with too little vitamin D can be bad for the window to your eyes. The three-layer, [Read More]

CUMC researchers capture first snapshot of key brain receptor in action
CUMC researchers capture first snapshot of key brain receptor in action

Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype [Read More]

Contact Your Senators About Health Care
Contact Your Senators About Health Care

/About-the-Society/News/Contact-Your-Senators-About-Health-Care [Read More]

Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS
Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS

/About-the-Society/News/Paper-Published-on-Recommendations-for-Speeding-Re [Read More]